English (UK)
中文版Mr. Hanson Lo
Huahai Investment Co, Ltd is a young, China-based firm backed by the Huahai Pharmaceuticals Group, a listed company in the Shanghai Stock Exchange. Our twin missions are to make investment as well as partnership deals in the healthcare sector.
Huahai Investment Co., Ltd
Director, BDLeila Lu
A joint venture with AstraZeneca, focusing on introducing life science companies into Wuxi and develop the biopharmaceutical industry in the city.
Wuxi ICampus Int'l Life Science Industrial Park
Vice DirectorMr. Avery Lu
We bring foundational science and commercial viability together for social and market impact.
We provide a human innovation ecosystem offering commercially focused support for inventors.
DEEP TECH FUNDING REINVENTED WITH SCIENCE, FOR SCIENCE
6 practice areas: AI, Robotics, Life Science, Quantum Computing, Energy, Secure Platforms & Networks
We provide a human innovation ecosystem offering commercially focused support for inventors.
DEEP TECH FUNDING REINVENTED WITH SCIENCE, FOR SCIENCE
6 practice areas: AI, Robotics, Life Science, Quantum Computing, Energy, Secure Platforms & Networks
Aventurine Capital Management, LLC
Investment Research LeadChunhua Lu
InnoCare is a commercial stage biopharmaceutical company committed to discovering, developing, and commercializing first-in-class and/or best-in-class drugs for the treatment of cancer and autoimmune diseases. We strategically focus on lymphoma, solid tumors, and autoimmune diseases with high unmet medical needs in China and worldwide. InnoCare has branches in Beijing, Nanjing, Shanghai, Guangzhou, New Jersey, and Boston.
Responsive Web Design powered by 